✦ LIBER ✦

P131 The neoadjuvant endocrinetherapy vs chemotherapy in postmenopausal woment with ER-positive breast cancer

✍ Scribed by V.F. Semiglazov; V.V. Semiglazov; V.G. Ivanov; E.R. Zhiltzova; A.E. Kletsel; G.A. Dashyan; A.A. Bozhok; R.M. Paltuev; L.M. Berstein; P.V. Krivorotko

Book ID: 114316044
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 45 KB
Volume: 16
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(07)70191-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P85 Direct comparison of primary (neoadj

P85 Direct comparison of primary (neoadjuvant) endocrine therapy vs primary chemotherapy in postmenopausal women with ER-positive breast cancer

✍ V. Semiglazov; V. Ivanov; A. Bozhok; A. Kletzel; E. Ziltzova; O. Melnikova; R. P 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Preoperative hormonal therapy vs chemoth

Preoperative hormonal therapy vs chemotherapy in postmenopausal ER-positive breast cancer patients

✍ V.F Semiglazov; V.V Semiglazov; V.G Ivanov; E.K Ziltsova; G.A Dashian; A Kletzel 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Primary endocrine therapy vs chemotherap

Primary endocrine therapy vs chemotherapy in postmenopausal ER-positive breast cancer patients

✍ V. Semiglazov; Kletsel; E. Zhiltsova; V. Ivanov; G. Dashyan; A. Bozhok; O. Melni 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Pathologic Response and Locoregional Out

Pathologic Response and Locoregional Outcome in Post-menopausal ER Positive Breast Cancer Patients Receiving Neoadjuvant Endocrine Therapy vs. Cytotoxic Chemotherapy

✍ K. Saigal; A.M. Saeed; J. Hurley; C. Takita; I.M. Reis; W. Zhao; T. Ambros; V. E 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

0177 Primary endocrine therapy versus ch

0177 Primary endocrine therapy versus chemotherapy in postmenopausal patients with ER-positive breast cancer: 5-year results

✍ V.F. Semiglazov; G.A. Dashyan; V.V. Semiglazov; E.K. Ziltsova; A.A. Malodusheva; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 53 KB

277 POSTER Breast-conserving surgery (BC

277 POSTER Breast-conserving surgery (BCS) following neoadjuvant endocrine therapy: exemestane (E) vs tamoxifene (T) in postmenopausal (PM) women with ER-positive breast cancer (T2N1, T3NO-1, T4NOMO)

✍ V. Semiglazov; E. Zhiltzova; V.V. Semiglazov; A. Kletsel; V. Ivanov; A. Bozhok; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 60 KB